O'Byrne K - Search Results

1

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

Circu M, Cardelli J, Barr MP, O'Byrne K, Mills G, El-Osta H. Circu M, et al. PLoS One. 2017 Sep 25;12(9):e0184922. doi: 10.1371/journal.pone.0184922. eCollection 2017. PLoS One. 2017. PMID: 28945807 Free PMC article.

2

Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer.

Swinson DE, O'Byrne KJ. Swinson DE, et al. Clin Lung Cancer. 2006 Jan;7(4):250-6. doi: 10.3816/CLC.2006.n.002. Clin Lung Cancer. 2006. PMID: 16512978 Review.

3

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.

Baird AM, Gray SG, O'Byrne KJ. Baird AM, et al. PLoS One. 2011 Jan 27;6(1):e14593. doi: 10.1371/journal.pone.0014593. PLoS One. 2011. PMID: 21298036 Free PMC article.

4

The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

O'Flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, O'Byrne K. O'Flaherty JD, et al. J Thorac Oncol. 2012 Dec;7(12):1880-1890. doi: 10.1097/JTO.0b013e31826bfbc6. J Thorac Oncol. 2012. PMID: 23154562 Free article. Review.

5

Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer.

Paul I, Chacko AD, Stasik I, Busacca S, Crawford N, McCoy F, McTavish N, Wilson B, Barr M, O'Byrne KJ, Longley DB, Fennell DA. Paul I, et al. Cell Death Dis. 2012 Dec 20;3(12):e449. doi: 10.1038/cddis.2012.186. Cell Death Dis. 2012. PMID: 23254292 Free PMC article.

6

Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ. Barr MP, et al. PLoS One. 2013;8(1):e54193. doi: 10.1371/journal.pone.0054193. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349823 Free PMC article.

7

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

Godwin P, Baird AM, Heavey S, Barr MP, O'Byrne KJ, Gately K. Godwin P, et al. Front Oncol. 2013 May 16;3:120. doi: 10.3389/fonc.2013.00120. eCollection 2013. Front Oncol. 2013. PMID: 23720710 Free PMC article.

8

The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer.

O'Byrne KJ, Barr MP, Gray SG. O'Byrne KJ, et al. Cancers (Basel). 2011 Mar 17;3(1):1426-53. doi: 10.3390/cancers3011426. Cancers (Basel). 2011. PMID: 24212667 Free PMC article.

9

The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.

Barr MP, Souan L, MacGabhann P, Müller J, Al Ashhab M, Jasser M, Hamza K, Al Hassoon S, Kuhn U, Infante D, Lawlor D, Gately K, Amireh E, O'Byrne K, Sughayer MA. Barr MP, et al. Biopreserv Biobank. 2014 Feb;12(1):3-12. doi: 10.1089/bio.2013.0072. Biopreserv Biobank. 2014. PMID: 24620764 Free PMC article.

10

Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.

Heavey S, Godwin P, Baird AM, Barr MP, Umezawa K, Cuffe S, Finn SP, O'Byrne KJ, Gately K. Heavey S, et al. Cancer Biol Ther. 2014 Oct;15(10):1367-77. doi: 10.4161/cbt.29841. Epub 2014 Jul 15. Cancer Biol Ther. 2014. PMID: 25025901 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters